Temple Research Suggests FDA-Approved Drugs Might Prevent Alzheimer’s By Mark TerryMay 3, 2023 The FDA approved Biogen’s Aduhelm (aducanumab) to treat early Alzheimer’s in June of 2021. Then, in 2022, [….]
The Philadelphia region, which includes Delaware and Southern New Jersey, is emerging as one of the top areas in the U.S. for the life sciences. So-called “Cellicon Valley” has numerous top academic institutions, and a range of biopharma companies working in drug discovery and development, as well as contract research organizations that manufacture and help deliver drugs. BioBuzz rounds up some of the leading companies in the region looking for top talent, with examples of a few of the jobs they’re currently hiring for.